Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
An affiliated shareholder of PHR has filed a Form 144 notice of intent to sell 6,038 shares of common stock. The planned sale is to be executed through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $98,762.36 and an approximate sale date of 01/16/2026.
The 6,038 common shares were acquired on 01/15/2026 through restricted stock vesting from the issuer as compensation. The filing also lists recent sales over the past three months, including multiple common stock sales by David Linetsky and one by Jessica Weiss, with gross proceeds ranging from about $1,549.72 to $103,845.36. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
Amy Vanduyn filed a Rule 144 notice to sell 2,202 common shares of PHR through Fidelity Brokerage Services LLC, with an aggregate market value of $36,017.67. The shares are listed on the NYSE and the approximate sale date indicated is January 16, 2026.
The 2,202 shares to be sold were acquired on January 15, 2026 via restricted stock vesting as compensation. Over the past three months, Vanduyn has sold additional PHR common shares, including 639 shares on October 17, 2025 for gross proceeds of $14,288.81, 2,602 shares on January 8, 2026 for $44,252.47, and 687 shares on January 15, 2026 for $11,252.72.
An insider of PHR, Allison C. Hoffman, has filed a notice of proposed sale of 3,995 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 01/16/2026 and an aggregate market value of $65,345.42.
The securities were acquired on 01/15/2026 via restricted stock vesting from the issuer as compensation. Over the past three months, Hoffman has sold additional common shares of the issuer, including 1,241 shares on 10/17/2025 for $27,750.25, 6,585 shares on 01/08/2026 for $111,991.75, and 1,106 shares on 01/15/2026 for $18,115.73.
PHR insider Chaim Indig filed a notice of proposed sale under Rule 144 for 9,595 shares of common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 01/16/2026 on the NYSE. These shares were acquired on 01/15/2026 via restricted stock vesting from the issuer as compensation.
Over the prior three months, Chaim Indig sold additional common shares of the same issuer, including 3,163 shares on 10/17/2025 for gross proceeds of $70,728.48, 8,440 shares on 01/08/2026 for $143,539.92, and 3,038 shares on 01/15/2026 for $49,760.92. The notice includes a representation that he is not aware of undisclosed material adverse information about the issuer’s operations.
Balaji Gandhi filed a Rule 144 notice to sell 4,687 shares of common stock through Fidelity Brokerage Services LLC on or about 01/16/2026 on the NYSE. These shares were acquired on 01/15/2026 via restricted stock vesting from the issuer as compensation, with full payment recorded on the same date.
During the prior three months, Gandhi sold 885 shares of common stock on 10/17/2025 for gross proceeds of 19,789.66, 8,009 shares on 01/08/2026 for 136,209.87, and 975 shares on 01/15/2026 for 15,970.01.
PHR received a Rule 144 notice for a planned sale of common stock by Evan Roberts. The filing states he intends to sell 6,268 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $102,524.42 and an approximate sale date of 01/16/2026.
The shares to be sold were acquired on 01/15/2026 via restricted stock vesting from the issuer as compensation, with 6,268 securities acquired and paid as compensation on that date. The notice also lists prior sales of PHR common stock by Evan Roberts during the past three months, including transactions on 10/17/2025, 01/08/2026, and 01/15/2026 with stated share amounts and gross proceeds. By signing, the seller represents he is not aware of undisclosed material adverse information about the issuer.
An insider has filed a Rule 144 notice to sell 687 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 01/15/2026. These shares were acquired on 01/14/2026 via restricted stock vesting from the issuer as compensation.
Over the prior three months, the same seller, Amy Vanduyn, sold 639 common shares on 10/17/2025 for gross proceeds of $14,288.81 and 2,602 common shares on 01/08/2026 for gross proceeds of $44,252.47. The filing notes that 60,287,003 shares of the issuer’s common stock were outstanding, providing a baseline for the size of these transactions.
A holder of common stock in PHR has filed a notice of intent to sell 1,106 shares through Fidelity Brokerage Services LLC, with an aggregate market value of $18,115.73. The shares are part of a restricted stock award that vested on January 14, 2026, and were acquired from the issuer as compensation on that date. The planned sale is listed for execution on or around January 15, 2026 on the NYSE.
The filing also lists prior sales by the same seller over the last three months, including 1,241 common shares sold on October 17, 2025 for $27,750.25, and 6,585 common shares sold on January 8, 2026 for $111,991.75. Common shares outstanding are reported at 60,287,003, providing context for the scale of these transactions.
The issuer of PHR common stock has filed a Form 144 for a planned sale of 1,743 common shares. The shares are expected to be sold on the NYSE through Fidelity Brokerage Services LLC, with an aggregate market value indicated as $28,549.47.
The 1,743 shares were acquired on January 14, 2026 through restricted stock vesting as compensation from the issuer, with payment also dated January 14, 2026. The notice also lists other recent sales in the past three months by individuals named David Linetsky and Jessica Weiss, including blocks of 2,059 and 6,106 common shares, with gross proceeds such as $46,041.71 and $103,845.36.
A Form 144 notice indicates that an insider associated with PHR plans to sell up to 975 shares of common stock through Fidelity Brokerage Services LLC on or about 01/15/2026 on the NYSE. The shares to be sold have an indicated aggregate market value of $15,970.01, and there were 60,287,003 shares of this class outstanding at the time referenced.
The 975 shares were acquired on 01/14/2026 via restricted stock vesting from the issuer as compensation. Over the prior three months, Balaji Gandhi sold additional common shares in two transactions: 885 shares on 10/17/2025 for $19,789.66 and 8,009 shares on 01/08/2026 for $136,209.87. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.